Sulfinyl Aziridines as Stereoselective Covalent Destabilizing Degraders of the Oncogenic Transcription Factor MYC

Journal:

Angewandte Chemie International Edition

Published:

2025-09-25

DOI:

10.1002/anie.202508518

Affiliations:

7

Authors:

15

Go to article

Institutions	Authors	Share
Novartis-Berkeley Translational Chemical Biology Institute, United States of America (USA)	4.500000	0.30
Novartis Biomedical Research, United States of America (USA)	4.000000	0.27
University of California, Berkeley (UC Berkeley), United States of America (USA)	3.500000	0.23
Novartis Biomedical Research, Switzerland	2.000000	0.13
Innovative Genomics Institute (IGI), United States of America (USA)	1.000000	0.07

Interested in Oncology and Carcinogenesis?